|
PTPRG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.554020E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.676300E-03 |
| Normal-vs-Stage2 |
3.179800E-01 |
| Normal-vs-Stage3 |
2.087800E-01 |
| Normal-vs-Stage4 |
3.815600E-01 |
| Stage1-vs-Stage2 |
4.279600E-01 |
| Stage1-vs-Stage3 |
7.190800E-01 |
| Stage1-vs-Stage4 |
3.807000E-01 |
| Stage2-vs-Stage3 |
7.621800E-01 |
| Stage2-vs-Stage4 |
9.524400E-01 |
| Stage3-vs-Stage4 |
7.273200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.298400E-02 |
| Normal-vs-AfricanAmerican |
1.284580E-01 |
| Normal-vs-Asian |
1.833830E-01 |
| Caucasian-vs-AfricanAmerican |
3.748600E-01 |
| Caucasian-vs-Asian |
8.060200E-01 |
| AfricanAmerican-vs-Asian |
6.521200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.431700E-02 |
| Normal-vs-Female |
2.157500E-02 |
| Male-vs-Female |
7.680600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.209640E-02 |
| Normal-vs-Age(41-60Yrs) |
5.346200E-02 |
| Normal-vs-Age(61-80Yrs) |
5.233200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.931000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.358400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.995600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.195800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.653170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.179000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.347600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.582800E-03 |
| Classical-VS-Follicular |
7.183800E-01 |
| Classical-VS-Other |
6.376400E-02 |
| Classical-VS-Normal |
2.284200E-03 |
| Tall-VS-Follicular |
1.601780E-01 |
| Tall-VS-Other |
2.149200E-01 |
| Tall-VS-Normal |
7.331400E-01 |
| Follicular-VS-Other |
3.870500E-02 |
| Follicular-VS-Normal |
2.144600E-01 |
| Other-VS-Normal |
1.443560E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.070440E-01 |
| Normal-vs-N1 |
1.657640E-01 |
| N0-vs-N1 |
8.262400E-01 |
|
|
